PFE vs PLTR: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Palantir Technologies Inc. โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-16.
Pfizer Inc. ยท Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
VS
Palantir Technologies Inc. ยท Technology
$142.76
-24.3% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
PFE has more upside to fair value
(+30.1%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
PFE |
PLTR |
| Current Price |
$26.91 |
$142.76 |
| Fair Value Estimate |
$35.00 |
$108.00 |
| Upside to Fair Value |
+30.1%
|
-24.3%
|
| Market Cap |
$153.0B |
$327.1B |
| Forward P/E |
9.5x
|
209.7x
|
| EV / EBITDA |
13.8x
|
โ
|
| Price / Sales |
2.4x
|
73.1x
|
| Price / FCF |
16.8x
|
155.7x
|
| Revenue Growth YoY |
-1.6%
|
+19.1%
|
| Gross Margin |
70.3%
|
82.4%
|
| Operating Margin |
24.7%
|
31.6%
|
| Return on Equity |
9.0%
|
25.7%
|
| Dividend Yield |
6.4% |
โ |
| FCF Yield |
5.9%
|
0.6%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seagโฆ
Palantir Technologies develops data analytics and AI software platforms like Gotham and Foundry for government and commercial clients. The business excels with high margins (gross 82.4%, net 36.3%), accelerating growth (Q4 FY2025 revenue up 70% YoY to $1.41B, 2026 guidance $7.19B implying 61% growth), and strong moats in defense and enterprise AI, but trades expensively at 73x P/S versus 5-year mโฆ
Accumulation Zones
| Metric |
PFE |
PLTR |
| Zone Low |
$25.00 |
$81.00 |
| Zone High |
$29.00 |
$92.00 |
| In Buy Zone? |
Yes
|
No
|